Report Overview
Global AI in Medical Imaging Market size is expected to be worth around US$ 16.88 Billion by 2034 from US$ 1.70 Billion in 2024, growing at a CAGR of 25.8% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 45.2% share with a revenue of US$ 0.77 Billion.
The global AI in Medical Imaging Market is rapidly transforming diagnostic healthcare by integrating artificial intelligence into radiology and medical imaging workflows. AI-powered software enables healthcare professionals to detect diseases more accurately, automate image analysis, and improve clinical decision-making while reducing reporting time. Increasing demand for early disease diagnosis, growing imaging volumes, and shortages of skilled radiologists are accelerating the adoption of AI technologies across hospitals and diagnostic centers.
Applications span neurology, cardiology, oncology, orthopedics, and pulmonary care, supporting faster and more precise diagnoses. Advances in deep learning algorithms, cloud computing, and medical image analytics continue to enhance the capabilities of AI-enabled imaging systems. Governments and healthcare organizations are also investing in digital health infrastructure and precision medicine, creating favorable conditions for AI adoption. Integration with electronic health records and cloud-based platforms further strengthens workflow efficiency and data accessibility.
As regulatory approvals for AI-enabled imaging devices continue to increase and healthcare providers seek improved diagnostic accuracy, the AI in Medical Imaging Market is expected to witness sustained expansion, supporting better patient outcomes and more efficient healthcare delivery worldwide.
Click here for more information: https://market.us/report/ai-in-medical-imaging-market/
Key Takeaways
- Market Size: The global AI in Medical Imaging Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 16.88 billion by 2034, growing at a CAGR of 25.8% during the forecast period.
- By Modality: The market is segmented into CT Scan, MRI, X-rays, Ultrasound, and Nuclear Imaging. In 2024, the CT Scan segment dominated the market, accounting for 37.4% of the total market share.
- By Application: Based on application, the market is categorized into Neurology, Respiratory and Pulmonary, Cardiology, Breast Screening, Orthopedics, and Other Applications. Among these, the Neurology segment held the largest market share of 39.8% in 2024.
- By Technology: The market is segmented into Deep Learning, Natural Language Processing (NLP), Machine Learning, and Other Technologies. In 2024, the Deep Learning segment led the market, capturing 57.9% of the total market share.
- By End Use: Based on end use, the market is categorized into Hospitals, Diagnostic Imaging Centers, and Other End-Users. The Hospitals segment dominated the market in 2024, accounting for 53.7% of the total revenue share.
- By Region: North America dominated the global AI in Medical Imaging Market in 2024, securing a 45.2% market share.
Key Market Segments
- By Modality
- CT Scan
- MRI
- X-rays
- Ultrasound
- Nuclear Imaging
- By Application
- Neurology
- Respiratory and Pulmonary
- Cardiology
- Breast Screening
- Orthopedics
- Other Applications
- By Technology
- Deep Learning
- Natural Language Processing (NLP)
- Machine Learning
- Other Technologies
- By End Use
- Hospitals
- Diagnostic Imaging Centers
- Other End-Users
Market Key Players
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- IBM Watson Health
- Canon Medical Systems Corporation
- Zebra Medical Vision
- Aidoc
- ai
- Arterys
- ai
- Butterfly Network
- Freeno
- HeartFlow
- Radiology Partners
- Lunit
- Other key players
Market Dynamics
Driver
The increasing need for early disease detection and faster diagnostic workflows is a major driver of the AI in medical imaging market. Healthcare systems worldwide are experiencing growing imaging volumes due to aging populations and the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions. Artificial intelligence helps radiologists analyze medical images more quickly, identify subtle abnormalities, and improve diagnostic consistency. According to the World Health Organization (WHO), cancer accounted for approximately 20 million new cases and 9.7 million deaths in 2022, highlighting the need for advanced imaging technologies that support early diagnosis.
The U.S. Centers for Disease Control and Prevention (CDC) also reports that heart disease remains the leading cause of death in the United States, emphasizing the importance of accurate imaging for timely intervention. The U.S. Food and Drug Administration (FDA) has authorized more than 1,000 AI-enabled medical devices, with the majority designed for medical imaging applications. These developments encourage hospitals and diagnostic centers to integrate AI into radiology workflows, improving efficiency, reducing interpretation time, and supporting better clinical outcomes.
Trend
One of the most significant trends in the AI in medical imaging market is the growing adoption of deep learning algorithms integrated into routine radiology workflows. Deep learning models are increasingly used to detect tumors, fractures, strokes, pulmonary diseases, and retinal abnormalities from CT, MRI, X-ray, ultrasound, and mammography images. According to the National Institutes of Health (NIH), artificial intelligence is playing an expanding role in precision medicine by enabling more accurate image interpretation and personalized treatment planning.
The U.S. FDA continues to clear new AI-based imaging software for clinical use, supporting broader implementation across healthcare facilities. AI-assisted platforms can prioritize urgent cases, automate image segmentation, and improve workflow efficiency by reducing repetitive manual tasks for radiologists. Cloud computing and advanced graphics processing technologies have also accelerated the deployment of AI-powered imaging solutions in hospitals and diagnostic centers.
Integration with electronic health records and picture archiving and communication systems (PACS) enables seamless access to imaging data, making AI an increasingly valuable component of modern diagnostic imaging infrastructure and clinical decision support.
Restraint
Despite rapid technological progress, data privacy concerns, regulatory requirements, and clinical validation remain key restraints for the AI in medical imaging market. AI systems require large, high-quality imaging datasets for training and continuous improvement, raising concerns regarding patient confidentiality and secure data sharing. The U.S. Department of Health and Human Services (HHS) enforces strict patient privacy protections through the Health Insurance Portability and Accountability Act (HIPAA), requiring healthcare organizations to implement comprehensive safeguards for medical data.
The U.S. FDA also requires rigorous clinical evaluation before approving AI-enabled diagnostic devices, ensuring safety, effectiveness, and consistent performance across diverse patient populations. Additionally, algorithm bias caused by limited or non-representative training datasets can affect diagnostic accuracy in certain demographic groups.
Healthcare providers must invest in cybersecurity, continuous software monitoring, and periodic algorithm updates to maintain compliance and clinical reliability. These regulatory, technical, and financial challenges can increase implementation costs and slow the adoption of AI-based imaging solutions, particularly in smaller healthcare organizations with limited digital infrastructure.
Opportunity
Government support for digital health transformation and precision medicine presents significant opportunities for the AI in medical imaging market. Public health agencies worldwide are investing in artificial intelligence, cloud computing, and advanced medical imaging technologies to improve healthcare delivery and research capabilities. The National Institutes of Health (NIH) continues to fund AI research through programs that support biomedical imaging, cancer diagnostics, and clinical decision support systems.
The National Cancer Institute (NCI) promotes AI-based imaging technologies to enhance cancer screening, treatment planning, and disease monitoring. According to the World Health Organization (WHO), more than 120 countries have developed or are implementing national digital health strategies aimed at strengthening healthcare systems. Expanding telemedicine services, increasing deployment of cloud-based imaging platforms, and growing adoption of remote diagnostics are creating additional demand for AI-powered imaging solutions.
Emerging economies are also investing in healthcare infrastructure and radiology services to address shortages of imaging specialists. These initiatives provide long-term opportunities for technology developers to expand AI-enabled diagnostic platforms that improve accessibility, efficiency, and accuracy across diverse clinical settings.
Conclusion
The AI in Medical Imaging Market is expected to witness rapid expansion, growing from US$ 1.70 billion in 2024 to US$ 16.88 billion by 2034, registering a robust CAGR of 25.8%. Increasing adoption of AI-powered diagnostics, deep learning technologies, and precision medicine is fueling market growth. CT Scan (37.4%), Neurology applications (39.8%), Deep Learning technology (57.9%), and Hospitals (53.7%) dominated their respective segments in 2024. North America accounted for the largest regional share at 45.2%, reflecting strong technological adoption and healthcare investments.
Top comments (0)